Abstract
Medication-related osteonecrosis of the jaw (MRONJ) is a non-resolving lesion developing in the maxillary bones, that persists for more than 8 weeks. It is common in patients receiving antiresorptive and oncologic
medications such as bisphosphonates, denosumab and antiangiogenic drugs. So far, there is no effective treatment for its resolution.